Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Youngstown › NPI 1891228599
Hospital

Steward Northside Medical Center, INC.

Steward Northside Medical Center, INC. was paid $1.58M by Medicaid between Jan 2018 and Sep 2018, across 93 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.

33Billing provider infoSTEWARD NORTHSIDE MEDICAL CENTER, INC.
YOUNGSTOWN, OH 44504
33aNPI1891228599assigned 04/10/2017
28Total paid$1.58M
24GClaims49,084
24DCodes billed93
24AFirst – last monthJan 2018 – Sep 2018
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#92 of 101
Median peer was paid$22.32M
This provider vs. median0.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DOYLE, JOHN controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201849,084$1.58M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 25% 4,610 4,148 $395K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 3,949 3,717 $321K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 3,279 2,964 $288K
96361 Intravenous infusion, hydration; each additional hour 9.2% 1,094 958 $146K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.5% 740 663 $72K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.2% 711 680 $50K
80053 Comprehensive metabolic panel 3.0% 3,202 2,838 $48K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2.5% 326 253 $39K
70450 Computed tomography, head or brain; without contrast material 2.4% 258 227 $39K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.9% 199 183 $30K
D7140 Extraction, erupted tooth or exposed root 1.4% 428 166 $22K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.3% 1,085 884 $20K
81 more codes
83605 <1% 781 $11K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 40 $10K
84484 <1% 634 $8K
D2392 Resin-based composite - two surfaces, posterior, primary or permanent <1% 152 $8K
G0378 Hospital observation service, per hour <1% 126 $7K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 71 $7K
80048 Basic metabolic panel (calcium, ionized) <1% 397 $5K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 26 $5K
D2391 Resin-based composite - one surface, posterior, primary or permanent <1% 93 $5K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 339 $5K
80061 Lipid panel <1% 488 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 291 $4K
D0140 Limited oral evaluation - problem focused <1% 202 $4K
D1110 Prophylaxis - adult <1% 104 $3K
88142 <1% 202 $2K
D0330 Panoramic radiographic image <1% 54 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 115 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 81 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 25 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 53 $1K
D0150 Comprehensive oral evaluation - new or established patient <1% 48 $1K
D0220 Intraoral - periapical first radiographic image <1% 261 $1K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 3,510 $1K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,338 $1K
83880 <1% 114 $1K
D2393 Resin-based composite - three surfaces, posterior, primary or permanent <1% 19 $1K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 80 $926.75
D0272 Bitewings - two radiographic images <1% 97 $920.00
36415 Collection of venous blood by venipuncture <1% 3,304 $841.80
71046 Radiologic examination, chest; 2 views <1% 648 $819.19
D0120 Dental checkup, returning patient <1% 52 $804.84
85379 <1% 28 $591.71
83036 Hemoglobin; glycosylated (A1C) <1% 687 $487.35
85027 <1% 195 $380.63
81025 <1% 1,250 $371.86
87086 Culture, bacterial; quantitative colony count, urine <1% 519 $350.27
71045 Radiologic examination, chest; single view <1% 273 $339.38
96375 Therapeutic injection; each additional sequential IV push <1% 662 $320.22
81001 <1% 1,866 $307.74
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 814 $280.81
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,142 $279.90
87590 <1% 17 $278.35
82553 <1% 31 $267.42
84443 Thyroid stimulating hormone (TSH) <1% 282 $264.35
D1120 Dental cleaning, child <1% 12 $240.00
84703 <1% 172 $224.10
D1208 Topical application of fluoride, excluding varnish <1% 13 $195.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,119 $189.24
83690 <1% 531 $175.86
83735 <1% 162 $86.58
81003 <1% 588 $63.21
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 53 $32.14
85730 <1% 191 $28.38
85610 <1% 353 $28.20
82150 <1% 125 $28.16
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 775 $24.75
J7030 Infusion, normal saline solution , 1000 cc <1% 526 $19.58
87430 <1% 246 $10.85
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 183 $8.94
87081 <1% 45 $8.05
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 45 $8.05
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 887 $5.98
81002 <1% 134 $4.53
J3010 Injection, fentanyl citrate, 0.1 mg <1% 285 $2.68
J7120 Ringers lactate infusion, up to 1000 cc <1% 100 $2.64
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 35 $2.30
J1170 Injection, hydromorphone, up to 4 mg <1% 58 $1.63
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 141 $1.15
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 106 $0.49
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 27 $0.06
J2704 Injection, propofol, 10 mg 0% 275 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 70 $0.00
82550 0% 88 $0.00
74022 0% 19 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 27 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 16 $0.00
85007 0% 13 $0.00
87186 0% 44 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 166 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 47 $0.00
73562 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOYLE, JOHN (CFO)
Same official

Other billing entities under DOYLE, JOHN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.